Last update 21 Nov 2024

FTL-008.16

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
FTL008.16
Target
4-1BBL x 5T4
Mechanism
4-1BBL modulators(Tumor necrosis factor ligand superfamily member 9 modulators), 5T4 modulators(Trophoblast glycoprotein modulators)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmMalignant Solid Neoplasm
Inactive Indication-
Originator Organization
Sound Biopharmaceuticals Ltd.Sound Biopharmaceuticals Ltd.
Active Organization
Sound Biopharmaceuticals Ltd.Sound Biopharmaceuticals Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with FTL-008.16
NCT06410131 / Not yet recruitingPhase 1
A Phase 1, First-in-Human, Open-Label, Dose Escalation and Dose Expansion Study of FTL008.16, a Recombinant Anti-CD137 and Anti-5T4 Bispecific Antibody, in Patients With Advanced or Metastatic Solid Tumors
100 Clinical Results associated with FTL-008.16
Login to view more data
100 Translational Medicine associated with FTL-008.16
Login to view more data
100 Patents (Medical) associated with FTL-008.16
Login to view more data
100 Deals associated with FTL-008.16
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
CN
Sound Biopharmaceuticals Ltd.Sound Biopharmaceuticals Ltd.
01 Jun 2024
Malignant Solid NeoplasmIND Approval
US
Sound Biopharmaceuticals Ltd.Sound Biopharmaceuticals Ltd.
04 Feb 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free